loading page

Management of Lytic Bone Disease in Lymphoplasmacytic Lymphoma: A Case Report and Review of the Literature
  • +6
  • Mizba Baksh,
  • Liuyan Jiang,
  • Unnati Bhatia,
  • Victoria Alegria,
  • Taimur Sher,
  • Vivek Roy,
  • Asher Chanan-Khan ,
  • Sikander Ailawadhi,
  • Ricardo Parrondo
Mizba Baksh
Mayo Clinic Hospital Jacksonville
Author Profile
Liuyan Jiang
Mayo Clinic Hospital Jacksonville
Author Profile
Unnati Bhatia
Maulana Azad Medical College
Author Profile
Victoria Alegria
Mayo Clinic Hospital Jacksonville
Author Profile
Taimur Sher
Mayo Clinic Hospital Jacksonville
Author Profile
Vivek Roy
Mayo Clinic Hospital Jacksonville
Author Profile
Asher Chanan-Khan
Mayo Clinic Hospital Jacksonville
Author Profile
Sikander Ailawadhi
Mayo Clinic Hospital Jacksonville
Author Profile
Ricardo Parrondo
Mayo Clinic Hospital Jacksonville
Author Profile

Abstract

Waldenström Macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is often differentiated from myeloma based on the presence of lytic bone lesions (LBL). However, WM/LPL can present with LBL and management is poorly understood. We describe a case of an 81-year-old woman with LPL who presented with LBL and was successfully treated with chemoimmunotherapy.

Peer review status:IN REVISION

18 Jun 2021Submitted to Clinical Case Reports
22 Jun 2021Assigned to Editor
22 Jun 2021Submission Checks Completed
10 Jul 2021Reviewer(s) Assigned
26 Jul 2021Review(s) Completed, Editorial Evaluation Pending
05 Aug 2021Editorial Decision: Revise Minor